Compare Centene Corp (CNC) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs Novavax Inc — how do they compare? Centene Corp trades at $66.33 (market cap $32.89B), while Novavax Inc trades at $7.97 (market cap $1.30B). The key difference: Centene Corp is far larger — about 25.3× Novavax Inc's market cap, and Centene Corp is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| CNC | NVAX | |
|---|---|---|
Market Cap | $32.89B | $1.30B |
Sector | Health | Health |
52-Week High | $68.72 | $11.19 |
52-Week Low | $26.17 | $6.22 |
Enterprise Value | $21.93B | $879.40M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
